Werlinich Asset Management, LLC Quest Diagnostics Inc Transaction History

Werlinich Asset Management, LLC

$172 Billion
Q3 2024

A detailed history of Werlinich Asset Management, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 3,755 shares of DGX stock, worth $514,772. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,755

Previous 3,755 -0.0%

Holding current value

$514,772

Previous $516 Million 13.04%

% of portfolio

0.34%

Previous 0.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$125.91 - $144.34 $18,886 - $21,651	-150 Reduced 3.84%	3,755 $516 Million
Q1 2024 Apr 11, 2024	SELL	$123.78 - $142.11 $360,199 - $413,540	-2,910 Reduced 42.7%	3,905 $512 Million
Q4 2023 Jan 09, 2024	SELL	$120.62 - $141.12 $40,890 - $47,839	-339 Reduced 4.74%	6,815 $938 Million
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $19,985 - $23,766	164 Added 2.35%	7,154 $872 Million
Q1 2023 Nov 13, 2023	BUY	$131.53 - $155.76 $1,315 - $1,557	10 Added 0.14%	6,990 $989 Million
Q4 2022 Nov 13, 2023	SELL	$123.31 - $157.26 $10,481 - $13,367	-85 Reduced 1.2%	6,980 $1.09 Billion
Q3 2022 Nov 13, 2023	SELL	$121.77 - $141.1 $12,177 - $14,110	-100 Reduced 1.4%	7,065 $867 Million
Q2 2022 Nov 13, 2023	SELL	$127.07 - $145.39 $66,711 - $76,329	-525 Reduced 6.83%	7,165 $953 Million
Q1 2022 Nov 13, 2023	SELL	$129.09 - $164.35 $31,627 - $40,265	-245 Reduced 3.09%	7,690 $1.05 Billion
Q3 2021 Nov 13, 2023	SELL	$132.95 - $158.0 $14,624 - $17,380	-110 Reduced 1.37%	7,935 $1.15 Billion
Q1 2021 Nov 13, 2023	BUY	$114.63 - $133.34 $922,198 - $1.07 Million	8,045 New	8,045 $1.03 Billion

Others Institutions Holding DGX

# of Institutions

925

Shares Held

95.1M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.

Account

Werlinich Asset Management, LLC Quest Diagnostics Inc Transaction History